| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1375304 | Bioorganic & Medicinal Chemistry Letters | 2017 | 5 Pages |
A new series of triazole compounds possessing an amide-part were efficiently synthesized and their in vitro antifungal activities were investigated. The amide analogs showed excellent in vitro activity against Candida, Cryptococcus and Aspergillus species. The MICs of compound 23d against C. albicans ATCC24433, C. neoformans TIMM1855 and A. fumigatus ATCC26430 were ⩽0.008, 0.031 and 0.031 μg/mL, respectively, (MICs of fluconazole: 0.5, >4 and >4 μg/mL; MICs of itraconazole: 0.125, 0.25, 0.25 μg/mL). Furthermore, compound 23d was stable under acidic conditions.
Graphical abstractSynthesis and in vitro antifungal activities of a novel series of triazole antifungal agents wherein the diene part of CS-758 was replaced by an aryl-amide group are described.Figure optionsDownload full-size imageDownload as PowerPoint slide
